H&N and Skin (HNS) GEC-ESTRO Working Group critical review of recommendations regarding prescription depth, bolus thickness and maximum dose in skin superficial brachytherapy with flaps and customized moulds.

Humans Brachytherapy / methods Skin Neoplasms / radiotherapy Radiometry Prescriptions Radiotherapy Dosage
Bolus Brachytherapy Customized moulds Non-melanoma skin cancer Skin dose Superficial brachytherapy

Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
10 2022
Historique:
received: 06 02 2022
revised: 26 06 2022
accepted: 21 08 2022
pubmed: 29 8 2022
medline: 21 10 2022
entrez: 28 8 2022
Statut: ppublish

Résumé

The aim of this publication is the assessment of the existing guidelines for non-melanoma skin cancer (NMSC) superficial brachytherapy (BT) and make a critical review based on the existing literature about the maximum dose prescription depth, bolus thickness and maximum skin surface dose (D

Identifiants

DOI: 10.1016/j.radonc.2022.08.022 PMID: 36030932
pubmed: 36030932
pii: S0167-8140(22)04243-8
doi: 10.1016/j.radonc.2022.08.022
pii:
doi:

Types de publication

Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

122-132

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Victor Gonzalez-Perez (V)

Department of Medical Physics, Fundación Instituto Valenciano de Oncología (F.I.V.O.), Beltran Baguena 8, 46009 Valencia, Spain. Electronic address: vgonzalez@fivo.org.

Agata Rembielak (A)

Department of Clinical Oncology, The Christie NHS Foundation Trust, 550 Wilmslow Road, Manchester, M20 4BX Manchester, United Kingdom; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, M13 9PL Oxford Road, Manchester, United Kingdom. Electronic address: agata.rembielak@nhs.net.

Jose Luis Guinot (JL)

Department of Radiation Oncology, Fundación Instituto Valenciano de Oncología (F.I.V.O.), Beltran Baguena 8, 46009 Valencia, Spain. Electronic address: jguinot@fivo.org.

Ramin Jaberi (R)

Radiation Oncology Research Centre (RORC), Cancer Institute, Tehran University of Medical Sciences, Keshavarz Blvd, Qods Street, 1417863181 Tehran, Iran. Electronic address: rjaberi@tums.ac.ir.

Valentina Lancellotta (V)

UOC Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy. Electronic address: valentina.lancellotta@policlinicogemelli.it.

Renate Walter (R)

Department of Medical Physics, Universitätsklinikum Augsburg, Stenglinstr 2, 86156 Augsburg, Germany. Electronic address: Renate.Walter@klinikum-augsburg.de.

Anysja Zuchora (A)

Department of Medical Physics and Clinical Engineering, University Hospital Galway, Newcastle Road, Galway H91 YR71, Ireland. Electronic address: anysja.zuchora@hse.ie.

Ashwini Budrukkar (A)

Department of Radiation Oncology, Tata Memorial Hospital Homi Bhabha National Institute, Ernest Borges Marg, Parel, Mumbai 400012, India. Electronic address: ashwini.budrukkar@gmail.com.

György Kovács (G)

Università Cattolica del Sacro Cuore, Gemelli - Interacts, Rome, Italy. Electronic address: gyorgy.kovacs@unicatt.it.

Ina Jürgenliemk-Schulz (I)

Department of Radiation Oncology, University Medical Centre Utrecht, Lundlaan, 3584 Utrecht, the Netherlands. Electronic address: i.m.schulz@umcutrecht.nl.

Frank-André Siebert (FA)

Clinic of Radiotherapy, University Hospital of Schleswig-Holstein, Arnold-Heller-Straße 3, Haus L, 24105 Kiel, Germany. Electronic address: Frank-Andre.Siebert@uksh.de.

Luca Tagliaferri (L)

UOC Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy. Electronic address: luca.tagliaferri@policlinicogemelli.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › H&N and Skin (HNS) GEC-ESTRO Working Group...
questionsmedicales.fr › Thérapeutique › Radiothérapie › Curiethérapie › H&N and Skin (HNS) GEC-ESTRO Working Group...
questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Tumeurs cutanées › H&N and Skin (HNS) GEC-ESTRO Working Group...
questionsmedicales.fr › Techniques d'investigation › Radiométrie › H&N and Skin (HNS) GEC-ESTRO Working Group...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Services de santé › Services pharmaceutiques › Ordonnances › H&N and Skin (HNS) GEC-ESTRO Working Group...
questionsmedicales.fr › Thérapeutique › Radiothérapie › Dosimétrie en radiothérapie › H&N and Skin (HNS) GEC-ESTRO Working Group...